Back to search

Article

Exploring the Association Between Upadacitinib and Venous Thromboembolism: An Integrated Analysis of Adverse Drug Events and Network Toxicology Mechanisms

2025-10-10

Abstract excerpt

<title>Abstract</title> <p>Objective To investigate the association between upadacitinib and venous thromboembolism (VTE) and explore potential toxicological mechanisms by integrating adverse drug events (ADEs) data with network toxicology analyses. Methods A retrospective analysis of upadacitinib-related ADEs reported in the FAERS database from January 2004 to March 2025 was conducted. Signal detection methods i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a6972294-0a50-587c-87a2-290e69149184
DOI
10.21203/rs.3.rs-7223810/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Exploring the Association Between Upadacitinib and Venous Thromboembolism: An Integrated Analysis of Adverse Drug Events and Network Toxicology MechanismsDOI 10.21203/rs.3.rs-7223810/v1
Identification of potential biomarkers of venous thromboembolism in patients with COVID-19 via an integrated bioinformatic-based studySemantic proximity
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for OsimertinibSemantic proximity
A real-world pharmacovigilance study of brentuximab vedotin based on the FAERS database from 2011 to 2024Semantic proximity
Cross-Database Analysis of Fruquintinib-Associated adverse events: Insights from FAERS and VigiAccess databasesSemantic proximity
Real-World Safety Profile of Baricitinib and the Structural Basis of Viral Reactivation: A Multi-Disciplinary AnalysisSemantic proximity
Chronic Kidney Disease: A Benefit-Risk Panorama of Baricitinib through Integrating Network Toxicology, Molecular Docking and Real-World EvidenceSemantic proximity
Distinct Adverse Event Profiles of Eight Chemotherapeutic Agents: A FAERS Database Analysis Focusing on Peripheral NeuropathySemantic proximity
Pharmacovigilance Insights into Gastrointestinal Adverse Events of JAK Inhibitors: FAERS Signal Detection with Clinical and Pharmacological ImplicationseSemantic proximity
A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for TivozanibSemantic proximity
Real-World Data Analysis of Vascular and Lymphatic Adverse Events Associated with Anti-Tumor Angiogenesis Drugs: A WHO-VigiAccess StudySemantic proximity
Signal mining and risk analysis of the over-indications use of bevacizumabSemantic proximity
Risks associated with the combination of Darolutamide and Docetaxel in interstitial lung disease : a pharmacovigilance study based on the FAERS databaseSemantic proximity
Select a neighboring publication to make it the new centre.